AzTrials
AzTrials

Laryngeal MasksNCT04229862

Effect of Head Elevation on LMA Insertion

A study testing Laryngeal mask airway insertion in people with Laryngeal Masks and Urinary Bladder Neoplasms, run by Asan Medical Center at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the first attempt success rate of laryngeal mask airway insertion according to the degree of head elevation. Read more about this study

Who is it for?
Ages 20 to 79 years
Conditions the study is for
Laryngeal Masks, Urinary Bladder Neoplasms
What is being tested?
Laryngeal mask airway insertion
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteSouth Korea
Study dates
14 Feb 2020to 5 May 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 79 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who are scheduled transurethral bladder tumor resection under general anesthesia
  • 20-79 years of age
  • American Society of Anesthesiologists physical status ≤3
  • Patients who are voluntarily agreed to this clinical study

Who cannot join

  • History of difficult airway
  • Expected difficult airway by physical examination
  • Unstable teeth or teeth loss
  • Obesity (body mass index ≥ 30)
  • Recent history of upper respiratory infection
  • Patients who are not fasted or who are at risk of aspiration

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Asan Medical Center

    Seoul, 05505

Other trials in South Korea

About this study

Official title: Effect of Head Elevation on LMA Supreme Insertion in Patients Undergoing Transurethral Resection of Bladder Tumor: a Randomized Controlled Trial

The purpose of this study is to compare the first attempt success rate of laryngeal mask airway insertion according to the degree of head elevation.

Read the detailed description

The purpose of this study is to compare the first attempt success rate of laryngeal mask airway insertion between 7 cm head elevation and 14 cm head elevation in patients who undergoing transurethral bladder tumor resection.

Being tested
Laryngeal mask airway insertion
Medical subject headings
Urinary Bladder Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laryngeal mask airway insertionProcedure or surgery

    Laryngeal mask airway insertion in patients who undergoing transurethral bladder tumor resection

Study groups in NCT04229862
Study groupRoleWhat they receive
Evaluation with 14 cm high pillowExperimentalWhen inserting laryngeal mask airway, head elevation is performed using a 14 cm high pillow.
Receives: Procedure: Laryngeal mask airway insertion
Evaluation with 7 cm high pillowActive comparatorWhen inserting laryngeal mask airway, head elevation is performed using a 7 cm high pillow.
Receives: Procedure: Laryngeal mask airway insertion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. First attempt success rate

    The rate of success at the first attempt of laryngeal mask airway insertion

    Measured: Immediately after mask airway insertion

Secondary outcomes (7)
  1. The percentage of glottic opening score

    The percentage of glottic opening by fiberoptic view

    Measured: Immediately after mask airway insertion

  2. Laryngeal mask airway insertion-related patient satisfaction

    A seven-point Likert scale

    Measured: At postoperative 6 hours

  3. Second attempt success rate

    The rate of success at the second attempt of laryngeal mask airway insertion

    Measured: Immediately after mask airway insertion

  4. Third attempt success rate

    The rate of success at the third attempt of laryngeal mask airway insertion

    Measured: Immediately after mask airway insertion

  5. Oropharyngeal leak pressure

    Oropharyngeal leak pressure is measured as follows: After setting the expiratory valve to 30 cmH2O at a fixed gas flow rate of 3 L/min, the maximum inflation pressure is measured when a noise of gas leakage is heard in the oropharynx via a stethoscope.

    Measured: Immediately after mask airway insertion

  6. Reposition rate

    The rate of reposition after laryngeal mask airway insertion when ventilation is ineffective or air leaks

    Measured: After mask airway insertion (up to end of surgery)

  7. Complications associated with laryngeal mask airway insertion

    Complications related with laryngeal mask airway insertion such as cough, vomit, aspiration, regurgitation, bleeding, laryngospasm, and bronchospasm

    Measured: Up to postoperative 3 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2020
  2. Study start14 Feb 2020
  3. Primary completion5 Apr 2020
  4. Study completion5 May 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04229862
Sponsor's protocol ID
2020-0020
Status last verified
May 2020
First submitted
13 Jan 2020
Last updated
29 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Mohta M. Head elevation beyond sniffing position - An aid to airway management. J Anaesthesiol Clin Pharmacol. 2018 Apr-Jun;34(2):247-248. doi: 10.4103/joacp.JOACP_173_17. No abstract available.

    PubMed 30104838
  • Katsiampoura AD, Killoran PV, Corso RM, Cai C, Hagberg CA, Cattano D. Laryngeal mask placement in a teaching institution: analysis of difficult placements. F1000Res. 2015 Apr 29;4:102. doi: 10.12688/f1000research.6415.1. eCollection 2015.

    PubMed 26401265
  • Horton WA, Fahy L, Charters P. Defining a standard intubating position using "angle finder". Br J Anaesth. 1989 Jan;62(1):6-12. doi: 10.1093/bja/62.1.6.

    PubMed 2917111
  • Takenaka I, Aoyama K, Iwagaki T, Ishimura H, Kadoya T. The sniffing position provides greater occipito-atlanto-axial angulation than simple head extension: a radiological study. Can J Anaesth. 2007 Feb;54(2):129-33. doi: 10.1007/BF03022009.

    PubMed 17272252
  • Jun JH, Baik HJ, Kim JH, Kim YJ, Chang RN. Comparison of the ease of laryngeal mask airway ProSeal insertion and the fiberoptic scoring according to the head position and the presence of a difficult airway. Korean J Anesthesiol. 2011 Apr;60(4):244-9. doi: 10.4097/kjae.2011.60.4.244. Epub 2011 Apr 26.

    PubMed 21602973
  • Park JY, Yu J, Hong JH, Hwang JH, Kim YK. Head elevation and laryngeal mask airway Supreme insertion: A randomized controlled trial. Acta Anaesthesiol Scand. 2021 Mar;65(3):343-350. doi: 10.1111/aas.13742. Epub 2020 Nov 28.

    PubMed 33174199

Questions about this trial

What is this clinical trial studying?

A study testing Laryngeal mask airway insertion in people with Laryngeal Masks and Urinary Bladder Neoplasms, run by Asan Medical Center at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

First attempt success rate (time frame: Immediately after mask airway insertion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04229862, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in